Hysterosalpingographic evaluation following management of ectopic pregnancy.

IF 0.5 Q4 OBSTETRICS & GYNECOLOGY

Ceska Gynekologie-Czech Gynaecology Pub Date : 2025-01-01 DOI:10.48095/cccg2025222

Adel Aly Elboghdady, Mohamed Ibrahim Mohamed, Mohammed Farouk Abd El Azeem Farahat, Mohamed Ali Mohamed Mohamed, Emad Mohamed Atalla, Ahmed Abd Elkader Eltabakh, Abdall Khalel Ahmad, Yasser Momamed Said Diab, Gehad Fawzy Ali Ali Khalil, Mai Mohammed Metwally, Alshaimaa Rabie El Makawy, Adel Mohamed Ghit, Ibrahim Mohamed Ibrahim Mohamed Abo Eldahab, Fadila Mamdouh Elsayed

{"title":"Hysterosalpingographic evaluation following management of ectopic pregnancy.","authors":"Adel Aly Elboghdady, Mohamed Ibrahim Mohamed, Mohammed Farouk Abd El Azeem Farahat, Mohamed Ali Mohamed Mohamed, Emad Mohamed Atalla, Ahmed Abd Elkader Eltabakh, Abdall Khalel Ahmad, Yasser Momamed Said Diab, Gehad Fawzy Ali Ali Khalil, Mai Mohammed Metwally, Alshaimaa Rabie El Makawy, Adel Mohamed Ghit, Ibrahim Mohamed Ibrahim Mohamed Abo Eldahab, Fadila Mamdouh Elsayed","doi":"10.48095/cccg2025222","DOIUrl":null,"url":null,"abstract":"Objective: It is to assess the ipsilateral and contralateral tubal patency by hysterosalpingography following salpingostomy and methotrexate therapy for tubal pregnancy.Patients and methods: The study was conducted between September 2021 and October 2023. It was conducted in the radiodiagnosis and obstetrics and gynecology departments of the Al-Hussin and Al-Azher university hospitals. Patients who had undergone salpingostomy or received methotrexate treatment were included in this research. Three months after being discharged, the individuals who were seeking for fertility were assessed again for Fallopian tube patency using hysterosalpingographs. Two groups of women participated in the study: group I (N = 50) received methotrexate treatment, while group II (N = 50) had undergone salpingostomy management.Results: The two groups (medical and surgery) did not vary statistically significantly in preserving tubal patency. Following methotrexate therapy, the ipsilateral tubal patency was 72%, and following surgical management, it was 74%. Furthermore, following methotrexate therapy, contralateral tubal patency was 92%, and 90% following salpingostomy.Conclusion: The results point to comparable success rates with salpingostomy and methotrexate in preserving fallopian tube patency.","PeriodicalId":43333,"journal":{"name":"Ceska Gynekologie-Czech Gynaecology","volume":"90 3","pages":"222-225"},"PeriodicalIF":0.5000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ceska Gynekologie-Czech Gynaecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48095/cccg2025222","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: It is to assess the ipsilateral and contralateral tubal patency by hysterosalpingography following salpingostomy and methotrexate therapy for tubal pregnancy.

Patients and methods: The study was conducted between September 2021 and October 2023. It was conducted in the radiodiagnosis and obstetrics and gynecology departments of the Al-Hussin and Al-Azher university hospitals. Patients who had undergone salpingostomy or received methotrexate treatment were included in this research. Three months after being discharged, the individuals who were seeking for fertility were assessed again for Fallopian tube patency using hysterosalpingographs. Two groups of women participated in the study: group I (N = 50) received methotrexate treatment, while group II (N = 50) had undergone salpingostomy management.

Results: The two groups (medical and surgery) did not vary statistically significantly in preserving tubal patency. Following methotrexate therapy, the ipsilateral tubal patency was 72%, and following surgical management, it was 74%. Furthermore, following methotrexate therapy, contralateral tubal patency was 92%, and 90% following salpingostomy.

Conclusion: The results point to comparable success rates with salpingostomy and methotrexate in preserving fallopian tube patency.

查看原文本刊更多论文

宫外孕处理后宫腔输卵管造影评价。

目的：探讨输卵管妊娠输卵管造瘘及甲氨蝶呤治疗后宫腔输卵管造影对同侧和对侧输卵管通畅的影响。患者和方法：该研究于2021年9月至2023年10月进行。检查是在Al-Hussin和Al-Azher大学医院的放射诊断科和妇产科进行的。接受输卵管造口术或甲氨蝶呤治疗的患者纳入本研究。出院三个月后，寻求生育能力的个体再次使用子宫输卵管造影术评估输卵管通畅。两组妇女参加研究：I组（N = 50）接受甲氨蝶呤治疗，II组（N = 50）接受输卵管造口术治疗。结果：两组（内科和外科）在保持输卵管通畅方面差异无统计学意义。甲氨蝶呤治疗后同侧输卵管通畅率为72%，手术治疗后同侧输卵管通畅率为74%。此外，甲氨蝶呤治疗后，对侧输卵管通畅率为92%，输卵管造瘘后通畅率为90%。结论：输卵管造口术与甲氨蝶呤在保持输卵管通畅方面成功率相当。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ceska Gynekologie-Czech Gynaecology OBSTETRICS & GYNECOLOGY-

CiteScore

0.60

自引率

25.00%

发文量